• 1
    Sharp JT: Radiologic assessment as an outcome measure in rheumatoid arthritis. Arthritis Rheum 32: 221229, 1989
  • 2
    Fuchs HA, Kaye JJ, Callahan LF, Nance EP, Pincus T: Evidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease. J Rheumatol 16: 585591, 1989
  • 3
    Iannuzzi L, Dawson N, Zein N, Kushner I: Does drug therapy slow radiographic deterioration in rheumatoid arthritis? N Engl J Med 309: 10231028, 1983
  • 4
    Alarcón GS, López-Méndez A, Walter J, Boerbooms AMT, Russel AS, Walter J, Furst DE, Rau R, Drosos AA, Bartolucci AA: Radiographic evidence of disease modifying antirheumatic drugs tested in rheumatoid arthritis patients: a meta-analysis. J Rheumatol 19: 18681873, 1992
  • 5
    Felson DT, Anderson JJ, Meenan RF: The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis: results of two metaanalyses. Arthritis Rheum 33: 14491461, 1990
  • 6
    Wilske KR, Healey LA: Remodelling the pyramid-a concept whose time has come. J Rheumatol 16: 565567, 1989
  • 7
    Furst DE: Should methotrexate be used to treat early rheumatoid arthritis? Semin Arthritis Rheum 23 (Suppl 2): 3943, 1994
  • 8
    Wilke WS, Sweeney TJ, Calabrese LH: Models of combination therapy with disease modifying antirheumatic drugs: early, aggressive therapy for rheumatoid arthritis: concerns, descriptions and estimate of outcome. Semin Arthritis Rheum 23 (Suppl 1): 2641, 1994
  • 9
    Kingsley GH, Panayi GS, Lanchbury JSS: Immunotherapy of rheumatic diseases: practice and prospects. Immunol Today 12: 177179, 1991
  • 10
    Van Rijthoven AWAM, Dijkmans BAC, Goei The HS, Hermans J, Montnor-Beckers ZL, Jacobs PC, Cats A: Cyclosporine treatment for rheumatoid arthritis: a placebo controlled double-blind multicentre study. Ann Rheum Dis 45: 726731, 1986
  • 11
    Førre Ø, Bjerkhoel F, Salvesen CF, Berg KJ, Rugstad HE, Saelid G, Mellbye OJ, Kåss E: An open, controlled, randomized comparison of cyclosporine and azathioprine in the treatment of rheumatoid arthritis: a preliminary report. Arthritis Rheum 30: 8892, 1987
  • 12
    Dougados M, Awada H, Amor B: Cyclosporine in rheumatoid arthritis: a double-blind, placebo-controlled study in 52 patients. Ann Rheum Dis 47: 127133, 1988
  • 13
    Yocum DE, Klippel JH, Wilder RL, Gerber NL, Austin HA, Wahl SM, Lesko L, Minor JR, Preuss HG, Yarboro C, Berkebile C, Dougherty S: Cyclosporin A in severe treatment of refractory rheumatoid arthritis. Ann Intern Med 109: 863869, 1988
  • 14
    Dougados M, Luchesne L, Awada H, Amor B: Assessment of efficacy and acceptability of low dose cyclosporin in patients with rheumatoid arthritis. Ann Rheum Dis 48: 550556, 1989
  • 15
    Tugwell P, Bombardier C, Gent M, Bennett KJ, Bensen WG, Carette S, Chalmers A, Esdaile JM, Klinkhoff AV, Kraag GR, Ludwin D, Roberts R: Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis. Lancet 335: 10511055, 1990
  • 16
    Van Rijthoven AWAM, Dijkmans BAC, Goei The HS, Meijers KA, Montnor-Beckers ZL, Moolenburgh JD, Boers M, Cats A: Comparison of cyclosporine and D-penicillamine for rheumatoid arthritis: a randomized double-blind study. J Rheumatol 18: 815820, 1991
  • 17
    Landewé RBM, Goei Thé HS, van Rijthoven AWAM, Breedveld FC, Dijkmans BAC: A randomized double-blind 24-week controlled study of low-dose cyclosporine versus chloroquine for early rheumatoid arthritis. Arthritis Rheum 37: 637643, 1994
  • 18
    An International Consensus Report: The use of cyclosporin A in rheumatoid arthritis. Br J Rheumatol 32 (suppl 1): 13, 1993
  • 19
    Førre Ø and the Norwegian Arthritis Study Group: Radiologic evidence of disease modification in rheumatoid arthritis patients treated with cyclosporine: results of a 48-week multicenter study comparing low-dose cyclosporine with placebo. Arthritis Rheum 37: 15061512, 1994
  • 20
    Paulus HE, Bulpitt KJ: DC-ART classification: review of relevant clinical studies. J Rheumatol 21 (suppl 41): 822, 1994
  • 21
    Pincus T: Rheumatoid arthritis: disappointing long-term outcomes despite successful short-term clinical trials. J Clin Epidemiol 41: 10371041, 1988
  • 22
    Sharp JT, Wolfe F, Corbett M, Isomaki H, Mitchell DM, Furst DE, Sibley J, Shipley M: Radiological progression in rheumatoid arthritis: how many patients are required in a treatment trial to test disease modification? Ann Rheum Dis 52: 332337, 1993
  • 23
    Brook A, Corbett M: Radiographic changes in early rheumatoid disease. Ann Rheum Dis 36: 7173, 1977
  • 24
    Larsen A, Thoen J: Hand radiography of 200 patients with rheumatoid arthritis repeated after an interval of one year. Scand J Rheumatol 16: 395401, 1987
  • 25
    Möttönen TT: Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis. Ann Rheum Dis 47: 648653, 1988
  • 26
    Van der Heijde DMFM, van Leeuwen MA, van Riel PLCM, Koster AM, van't Hof MA, van Rijswijk M, van de Putte LBA: Biannual radiographic assessment of hands and feet in a three-year prospective followup of patients with early rheumatoid arthritis. Arthritis Rheum 35: 2634, 1992
  • 27
    Salaffi F, Ferraccioli GF: Progress of the anatomical damage in rheumatoid hands: radiography of the natural course of the disease or of the course during treatment? Scand J Rheumatol 18: 119120, 1989
  • 28
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315324, 1988
  • 29
    Pasero G, Pellegrini P, Ambanelli U, Ciompi ML, Colamussi V, Ferraccioli G, Barbieri P, Mazzoni MR, Menegale G, Trippi D: Controlled multicenter trial of tiopronin and D-penicillamine for rheumatoid arthritis. Arthritis Rheum 25: 923929, 1982
  • 30
    Holt DW, Johnston A, Roberts NB, Tredger JM, Trull AK: Methodological and clinical aspects of cyclosporin monitoring: report of the Association of Clinical Biochemists task force. Ann Clin Biochem 31: 420446, 1994
  • 31
    Huskisson EC: Measurement of pain. J Rheumatol 5: 768769, 1982
  • 32
    Ritchie DM, Boyle JA, McInnes JM, Jasani MK, Dalakos TG, Grieveson P, Buchanan WW: Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. QJM 147: 393406, 1968
  • 33
    Lee P, Webb J, Anderson JA, Buchanan WW: A method for assessing the therapeutic potential of anti-inflammatory, antirheumatic drugs in rheumatoid arthritis. BMJ 2: 685688, 1973
  • 34
    Cockroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16: 3141, 1976
  • 35
    Ferraccioli GF: Radiographic assessment of rheumatoid arthritis: controversies and perspective. Clin Exp Rheumatol 8: 529530, 1990
  • 36
    Larsen A, Dale K, Eek M, Pahle J: Radiographic evaluation of rheumatoid arthritis by standard reference films. J Hand Surg 8: 667669, 1983
  • 37
    Gillings D, Koch G: The application of the principle of intention-to-treat to the analysis of clinical trials. Drug Inform J 25: 411424, 1991
  • 38
    Marubini E, Valsecchi MG: Analysing survival data from clinical trials and observational studies. In. Wiley Statistics in Practice Series. Chichester, UK, J Wiley & Sons, 1995
  • 39
    Scott DL, Coulton BL, Bacon PA, Popert AJ: Methods of x-ray assessment in rheumatoid arthritis: a re-evaluation. Br J Rheumatol 24: 3139, 1985
  • 40
    Scott DL, Adebajo AO, El Badaway S, Kirwan J, van de Putte LBA, van Riel PLCM: DC-ART: preventing or significantly decreasing the rate of progression of structural joint damage. J Rheumatol 21 (suppl 41): 3640, 1994
  • 41
    Tunn EJ, Bacon PA: Differentiating persistent from self-limiting symmetrical synovitis in an early arthritis clinic. Br J Rheumatol 32: 97103, 1993
  • 42
    Sharp JT, Wolfe F, Mitchell DM, Bloch DA: The progression of erosion and joint space narrowing scores in rheumatoid arthritis during the first twenty-five years of disease. Arthritis Rheum 34: 660668, 1991
  • 43
    Jeurissen MEC, Boerbooms AMTh, van de Putte L, Doesburg WH, Lemmens AM: Influence of methotrexate and azathioprine on radiologic progression in rheumatoid arthritis. Ann Intern Med 114: 9991004, 1991
  • 44
    Herbon G, Rau R, Menninger H, Ezhardt D, Schmitt J: Data of two years of the comparative study of methotrexate/aurothiomalate in 102 patients. Z. Rheumatol 51: 163171, 1992
  • 45
    Tugwell P: Cyclosporine in the treatment of rheumatoid arthritis. J Autoimmun 5 (Suppl A): 231240, 1992
  • 46
    Torley H, Yocum D: Effects of dose and treatment duration on adverse experiences with cyclosporine in RA: analysis of North American trials (abstract). Arthritis Rheum 37 (Suppl 9): S334, 1994
  • 47
    Landewe RBM, Goei The HS, van Rijthoven AWAM, Rietveld JR, Breedveld FC, Dijkmans BAC: Cyclosporin in common clinical practice: an estimation of the benefit risk ratio in patients with rheumatoid arthritis. J Rheumatol 21: 16311636, 1994
  • 48
    International Kidney Biopsy Registry of Cyclosporin (Sandim-munR) in Autoimmune Diseases: Renal morphology after cyclosporin A therapy in rheumatoid arthritis patients. Br J Rheumatol 32 (suppl 1): 6571, 1993
  • 49
    Feutren G, Mihatsch MJ, For the International Kidney Biopsy Registry of Cyclosporin In Autoimmune Diseases: Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. N Engl J Med 326: 16541660, 1992
  • 50
    Van der Heijde DMFM, van Riel PLCM, van Rijsnijk MH, van de Putte LBA: Influence of prognostic features on the final outcome in rheumatoid arthritis: a review of the literature. Semin Arthritis Rheum 17: 284292, 1988
  • 51
    Dawes PT: Radiological assessment of outcome in rheumatoid arthritis. Br J Rheumatol 27 (Suppl 1): 2136, 1988
  • 52
    Pincus T, Callahan LF, Brooks RH, Fuchs HA, Olsen NJ, Kaye JJ: Self-report questionnaire scores in rheumatoid arthritis compared with traditional physical, radiographic, and laboratory measures. Ann Intern Med 110: 259266, 1989
  • 53
    Kurki P: Cyclosporin A in rheumatoid arthritis: future perspectives. Br J Rheumatol 32 (Suppl 1): 7678, 1993